|
|
Article: BRIEFING - ASIA HEALTH - MARCH 30, 2009.
- Article from:
- AsiaPulse News
- Article date:
- March 30, 2009
CopyrightCOPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
An executive briefing on Health for March 30, 2009, prepared by Asia Pulse (http://www.asiapulse.com), the real-time, Asia-based wire with exclusive news, commercial intelligence and business opportunities.
AUSTRALIA'S BIOTA IN MFG, MARKETING DEAL WITH DAIICHI SANKYO
MELBOURNE - Anti-infective drug developer Biota Holdings Ltd (ASX:BTA) said on Monday that Japanese pharmaceutical firm Daiichi Sankyo will manufacture and market the anti-flu compound CS-8958 in Japan, pending completion of Phase III clinical trials and registration of the drug.
Biota will receive an undisclosed royalty on sales of the drug and a number of fixed-sum payments upon ...